How to Detect Lead Poisoning: A Plain-Language Guide
How to detect lead poisoning is a question that often confuses home paint testing with medical exposure testing. The two are completely different. Lead poisoning is diagnosed only by a physician, only through a blood lead level (BLL) test, and only on a person. Home lead paint testing identifies a potential source of exposure in the built environment, not the diagnosis of poisoning in a body. This distinction is the most important takeaway from this guide. Anyone concerned about possible lead exposure for themselves or a family member should contact their primary care physician or pediatrician for a blood lead test. This guide summarizes CDC and pediatric clinical guidance current as of 2026 and is not medical advice for any specific individual; consult your physician for diagnosis and treatment.
Asbestos or biohazard concern? Speak with a certified contractor.
📞 Call (877) 742-8496The single answer: BLL testing by a physician
Lead poisoning is diagnosed by measuring blood lead concentration. A clinician orders a blood draw, the sample is processed by a laboratory using atomic absorption spectrometry or inductively coupled plasma mass spectrometry, and the result is reported in micrograms of lead per deciliter of blood. The CDC current reference value is 3.5 micrograms per deciliter, but the level was historically much higher and has been progressively lowered as research clarified the harm of low-level exposure. Any blood lead level above 3.5 micrograms per deciliter is currently considered elevated and triggers public health follow-up. Diagnosis of lead poisoning at clinically significant levels typically refers to levels of 10 micrograms per deciliter or higher, with severe poisoning often defined as 45 micrograms per deciliter or above.
Why home paint testing is not detection of poisoning
Home lead paint testing measures lead in paint, not lead in a person. A positive paint test identifies a potential source of exposure; it does not tell you whether anyone in the household has actually absorbed lead. Two homes with identical lead paint can have very different blood lead levels among residents because exposure depends on paint condition, dust generation, child age, hand-to-mouth behavior, and many other factors. A consumer rapid-test swab that turns positive on a windowsill does not mean a child living in the home has lead poisoning. The swab identifies the source; the blood test identifies the exposure. Both are important; neither substitutes for the other. The lead paint testing kit overview covers source-side testing in detail.
Who should be tested for lead poisoning
The CDC and the American Academy of Pediatrics recommend blood lead screening for children at ages 12 and 24 months if the child lives in or regularly visits a pre-1978 home, if the child has a sibling with elevated BLL, if the child is enrolled in Medicaid (Medicaid policy requires blood lead screening at these ages), or if the child is recently immigrated from a country with continued lead paint or leaded gasoline use. Adults at occupational risk including renovation contractors, construction workers, battery manufacturing workers, and certain industrial workers also receive periodic blood lead monitoring under OSHA standards. Pregnant women in pre-1978 housing or with other risk factors should discuss BLL testing with their obstetrician.
What the blood lead level number means
The result is a single number in micrograms per deciliter. The CDC reference value of 3.5 is not a “safe” level; it is the 97.5th percentile of U.S. childhood blood lead levels in recent national surveys. Children above the reference value warrant public health follow-up. Children below it are not necessarily safe; ongoing research continues to document health effects at very low exposure levels. The clinically significant thresholds are 5 mcg/dL (action level for many states), 10 mcg/dL (formerly the CDC “level of concern”), 45 mcg/dL (chelation therapy generally considered), and 70 mcg/dL (hospitalization typically required). Front Range pediatricians follow these thresholds when interpreting screening results.
Symptoms versus screening
Lead poisoning is largely asymptomatic at low exposure levels. Children with elevated BLLs in the 5-15 mcg/dL range typically show no obvious symptoms; the harm comes from subtle developmental and cognitive effects that emerge over time. Higher levels can produce symptoms including abdominal pain, irritability, fatigue, poor appetite, and developmental regression. Very high levels can cause seizures, coma, and death. The clinical reality is that symptoms are unreliable detection tools for lead poisoning at the levels typical in U.S. homes today. Screening through blood testing is the only reliable detection method. This is why CDC and AAP guidelines emphasize screening rather than waiting for symptoms.
The two-step screening protocol
Many primary care settings use a two-step BLL screening protocol. The first step is a capillary blood draw, typically a finger-stick, that yields a screening-level result. Capillary samples are easier to collect, especially in young children, but can be contaminated by lead dust on the skin if not carefully cleaned. Elevated capillary results are confirmed by a venous blood draw, which provides the diagnostic result of record. The venous result is what triggers public health follow-up, environmental investigation of the home, and any chelation or other treatment decisions. The two-step protocol balances screening accessibility with diagnostic reliability.
Lab methods used to measure blood lead
Two laboratory methods dominate clinical BLL testing. Graphite furnace atomic absorption spectrometry was historically the standard and remains in widespread use. Inductively coupled plasma mass spectrometry has become more common in recent years because of higher throughput and lower detection limits. Both methods are accurate when run by accredited laboratories and properly calibrated. Point-of-care devices like the LeadCare II analyzer use anodic stripping voltammetry to produce a result in minutes from a finger-stick sample; these devices are useful for screening in clinical settings but require confirmation by laboratory testing for any elevated result.
What happens after an elevated BLL is detected
An elevated BLL triggers a structured public health response. The pediatrician or primary care provider notifies the state or local health department. A public health investigator typically contacts the family to coordinate an environmental investigation of the home. A certified lead inspector then conducts paint testing, dust wipe sampling, and soil testing to identify the exposure source. The investigator may also test water and assess imported consumer products. Once the source is identified, remediation contractors work with the family on intact-paint stabilization, soil remediation, or other source control. For BLLs above 45 mcg/dL, chelation therapy may be considered to accelerate lead clearance from the body, though chelation has significant risks and is reserved for higher exposures.
How home paint testing fits into the picture
Home paint testing is the source-identification half of a two-part exposure framework. A homeowner who suspects lead exposure for their family follows two parallel pathways. The first is medical: contact the pediatrician or primary care physician to discuss BLL testing for at-risk family members. The second is environmental: commission a professional lead paint assessment by an EPA-certified inspector. The two pathways feed into each other. Medical testing confirms whether exposure has actually occurred; environmental testing identifies where the exposure came from so it can be eliminated. Neither is sufficient alone. The broader pre-1978 housing hazard guide walks through the environmental side of the framework.
Distinguishing lead paint testing from lead exposure testing
Three concrete distinctions matter for homeowners. First, paint testing tells you about paint; blood testing tells you about a person. Second, paint testing is done on surfaces and dust; blood testing is done on people. Third, paint testing kits are sold at hardware stores for screening; blood testing requires a physician’s order and laboratory processing. The internet sometimes blurs these categories with marketing that calls a paint test a “lead detection kit.” Read the fine print before purchase. A consumer kit that detects lead in paint or dust is not a lead poisoning detection kit, regardless of marketing language.
What detection cannot do
Blood lead detection identifies current and recent exposure. It does not provide a lifetime exposure history; lead clears the blood over weeks to months and is sequestered in bone for years. A normal current BLL does not mean a person was never exposed in the past. Bone lead testing using X-ray fluorescence is occasionally used in research settings to estimate cumulative exposure, but it is not routine clinical practice. The clinical takeaway is that BLL testing measures recent exposure and is most useful as part of ongoing screening for at-risk children, occupational workers, and pregnant women.
Cost, coverage, and access to BLL testing
Blood lead level testing is routine clinical work and is covered by most health insurance, including Medicaid. The federal Early and Periodic Screening, Diagnostic, and Treatment program requires Medicaid to cover blood lead screening for children at ages 12 and 24 months. Private insurance plans typically cover screening with no copay when ordered by a primary care physician. Out-of-pocket cost is typically modest, in the range of $30 to $100 for the lab test plus the cost of the office visit. State and local health departments often provide free screening for uninsured children. Front Range families can access screening through pediatricians, community health centers, and the Colorado Department of Public Health and Environment’s lead screening programs.
What to do while waiting for results
If a child has been screened for lead and is waiting for results, the family can take several precautionary steps in the interim. Wash hands frequently, especially before meals. Wet-mop and wet-wipe floors and windowsills weekly. Keep children away from chipping paint and bare soil near pre-1978 exterior walls. Feed children iron-rich and calcium-rich foods, which reduce lead absorption. Avoid renovation that disturbs paint until the home has been assessed by a certified lead inspector. None of these steps substitute for the screening result or for medical follow-up if the result is elevated, but they reduce exposure during the waiting period.
Detection in adults: occupational and incidental exposure
Adult lead exposure tends to track occupational categories. Renovation contractors disturbing pre-1978 paint, battery manufacturing workers, firing-range workers handling lead bullets, and certain metal fabrication workers all face elevated occupational lead exposure. OSHA requires periodic blood lead monitoring for workers in these settings. Adult homeowners doing their own renovation in pre-1978 housing should consider one-time BLL testing if the work involved aggressive sanding, scraping, or demolition without proper containment. Pregnant women are a special case because lead crosses the placenta and historic bone lead can mobilize during pregnancy. Obstetricians should be informed about pre-1978 housing history.
References
- CDC Blood Lead Reference Value — Centers for Disease Control and Prevention
- EPA Learn About Lead — U.S. Environmental Protection Agency
- NIEHS Lead Health Effects — National Institute of Environmental Health Sciences
- OSHA Lead Standard — Occupational Safety and Health Administration